ALM-412 is under clinical development by Almirall and currently in Phase I for Familial Adenomatous Polyposis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback